| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and CEO
1 company
Gill John is a Director at ALT. Recent filings cover 3 purchases and 2 sales. Those positions are worth an estimated $74K at current prices.
Gill John's largest disclosed position is in ALT as Director, worth about $74K. Net of sales, the recent Form 4 record there shows accumulation of 11,561 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | ALT Altimmune, Inc. | Director | Buy | 9,200 | $3.41 | $31,349.92 | +73.6% | -7.5% | - | |
| Dec 23, 2025 | ALT Altimmune, Inc. | Director | Buy | 12,500 | $4.10 | $51,250.00 | New | -14.0% | - | |
| Aug 12, 2022 | ALT Altimmune, Inc. | Director | Sell | 2,714 | $15.00 | $40,710.00 | -49.5% | -39.1% | -82.7% | |
| Nov 30, 2020 | ALT Altimmune, Inc. | Director | Sell | 8,425 | $11.92 | $100,426.00 | -42.9% | - | - | |
| Jun 2, 2017 | ALT Altimmune, Inc. | Director | Buy | 1,000 | $4.34 | $4,343.50 | +1.2% | - | - |